SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-188608
Filing Date
2014-05-08
Accepted
2014-05-08 06:55:56
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FROM 10-Q d692445d10q.htm 10-Q 579607
2 EX-10.1 d692445dex101.htm EX-10.1 17076
3 EX-31.1 d692445dex311.htm EX-31.1 6332
4 EX-31.2 d692445dex312.htm EX-31.2 6335
5 EX-32.1 d692445dex321.htm EX-32.1 3910
6 EX-32.2 d692445dex322.htm EX-32.2 3907
13 GRAPHIC g6924451.jpg GRAPHIC 6432
  Complete submission text file 0001193125-14-188608.txt   5481199

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT srpt-20140331.xml EX-101.INS 774544
8 XBRL TAXONOMY EXTENSION SCHEMA srpt-20140331.xsd EX-101.SCH 56143
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20140331_cal.xml EX-101.CAL 74918
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20140331_def.xml EX-101.DEF 199472
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20140331_lab.xml EX-101.LAB 422364
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20140331_pre.xml EX-101.PRE 323566
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 14822899
SIC: 2834 Pharmaceutical Preparations